Research and development (including non-cash stock-based compensation expense of 0.9 million and 0.6 million for three months ended june 30, 2026 and 2025, respectively and 1.8 million and 1.1 million for six months ended june 30, 2026 and 2025 respectively)
24,619
21,431
General and administrative (including non-cash stock-based compensation expense of 36.0 million and 1.2 million for the three months ended june 30, 2026 and 2025, respectively and 37.6 million and 2.3 million for six months ended june 30, 2026 and 2025 respectively
41,189
6,112
Total operating expenses
65,808
27,543
Loss from operations
-65,808
-27,543
Interest income, net
3,257
2,133
Research and development tax credit
236
567
Other expense, net
34
46
Total other income, net
3,459
2,654
Loss before income taxes
-62,349
-24,889
Income tax provision
251
519
Net loss
-62,600
-25,408
Foreign currency translation adjustment
18
15
Unrealized (loss) gain on available-for-sale securities
-557
-252
Comprehensive loss
-63,139
-25,645
Basic EPS
-1.78
-10.34
Diluted EPS
-1.78
-10.34
Basic Average Shares
35,236,214
2,456,766
Diluted Average Shares
35,236,214
2,456,766
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.